Psychological outcomes (depression) · people with substance use disorders
1 finding from 1 review
Completion of treatment: clonidine versus buprenorphine, inpatient setting · management of opium withdrawal
It is very uncertain whether pharmacological detoxification treatment changes completion of treatment: clonidine versus buprenorphine, inpatient… compared with other pharmacological detoxification treatment (very low certainty).
1 finding from 1 review
RR 1.04 [0.9, 1.2]
35 participants
Very low
Withdrawal symptoms · management of opium withdrawal
1 finding from 1 review
no estimate extracted
34 participants
Very low
Intervention not reported
Point‐prevalence abstinence rates at short‐term · adults with cannabis use disorder or frequent cannabis use
The intervention may leads to higher point‐prevalence abstinence rates at short‐term (low certainty).
1 finding from 1 review
Intervention not reported
Number commencing naltrexone maintenance treatment ‐ Buprenorphine comparison · patients with opioid withdrawal
The intervention probably leads to higher number commencing naltrexone maintenance treatment ‐ Buprenorphine… (moderate certainty).
1 finding from 1 review
Intervention not reported
Retained in naltrexone maintenance treatment or abstinent at 12 weeks ‐ Buprenorphine comparison · patients with opioid withdrawal
The intervention showed no clear difference in retained in naltrexone maintenance treatment or abstinent at 12… (moderate certainty).
1 finding from 1 review
Intervention not reported
Retention in treatment ‐ Old studies (pre 2000) objective · patients with opioid dependence
The intervention leads to higher retention in treatment ‐ Old studies (pre 2000) objective (high certainty).
1 finding from 1 review
Number of continuously abstinent women ‐ total · stopping or reducing alcohol consumption during pregnancy
Summary of findings table ‐ Any psychosocial intervention may leads to higher number of continuously abstinent women ‐ total compared with treatment (low certainty).
1 finding from 1 review
Number of drinks per day ‐ total · stopping or reducing alcohol consumption during pregnancy
1 finding from 1 review
Number of women who completed treatment ‐ total · stopping or reducing alcohol consumption during pregnancy
Summary of findings table ‐ Any psychosocial intervention showed no clear difference in number of women who completed treatment ‐ total compared with treatment (moderate certainty).
1 finding from 1 review
Adverse events ‐ not measured · stopping or reducing alcohol consumption during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawal signs and symptoms ‐ not measured · stopping or reducing alcohol consumption during pregnancy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Birthweight (g) · opiate‐dependent pregnant women
1 finding from 1 review
APGAR score (APGAR score ) · opiate‐dependent pregnant women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events for the mother · opiate‐dependent pregnant women
1 finding from 1 review
Serious adverse events for the child · opiate‐dependent pregnant women
1 finding from 1 review
Unacceptability of treatment (dropouts/exclusions during the trial) · opiate‐dependent pregnant women
1 finding from 1 review
Use of substance · opiate‐dependent pregnant women
Methadone showed no clear difference in use of substance compared with oral slow‐release morphine (low certainty).
1 finding from 1 review
Percent of days abstinent · co‐occurring depression and substance use disorders
2 findings from 1 review
Retention in treatment · co‐occurring depression and substance use disorders
It is very uncertain whether integrated CBT changes treatment retention compared with twelve Step Facilitation (very low certainty).
1 finding from 1 review